drugset / Press release
PEP07: A novel, brain penetrant oral Chk1 inhibitor for the treatment of AML and MCL (6th Annual DDR Inhibitors Summit 2023)
2023-01-25 · PharmaEngine · original pharmaengine.com ↗
PEP07: A novel, brain penetrant oral CHK1 inhibitor for the treatment of AML and MCL (6th Annual DDR Inhibitors Summit 2023)
The release as fetched from its publisher. pharmaengine.com ↗